Oncothyreon Inc (NASDAQ:ONTY)

1.75
Delayed Data
As of Apr 20
 +0.03 / +1.74%
Today’s Change
1.48
Today|||52-Week Range
3.60
-7.89%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$176.0M

Company Description

Oncothyreon, Inc. is clinical-stage bio-pharmaceutical company. The Company operates in a single business segment, Research and Development of therapeutic products for the treatment of cancer. Its cancer vaccines are designed to stimulate the immune system to attack cancer cells, while small molecule compounds are designed to inhibit the activity of specific cancer-related proteins. Oncothyreon was founded on September 7, 2007 and is headquartered in Seattle, WA.

Contact Information

Oncothyreon, Inc.
2601 4th Avenue
Seattle Washington 98121
P:(206) 801-2100
Investor Relations:

Employees

Shareholders

Other institutional36.27%
Individual stakeholders14.88%
Mutual fund holders14.51%

Top Executives

Robert L. KirkmanPresident, Chief Executive Officer & Director
Gary ChristiansonChief Operating Officer
Julia Marie EastlandCFO, Secretary & VP-Corporate Development
Scott Robert PetersonChief Scientific Officer
Diana HausmanChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account